Brainstorm Cell Therapeutics (BCLI) Tops Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
BrainStorm Cell Therapeutics Reports Third Quarter 2016 Financial Results
November 15, 2016 9:06 AM ESTHACKENSACK, N.J. and PETACH TIKVAH, Israel, Nov. 15, 2016 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (Nasdaq:Â BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today announced financial results and provided a business update for the third quarter ended September 30, 2016.
The CEO and senior management will host a corporate update call with shareholders in December (exact date and details will be published in a separate announcement).Â
Third Quarter 2016 and Recent Highlights
On July 18, Brainstorm announced positive top line data from a... More